Report On Australian Biotechnology

Main Category: Biology / Biochemistry
Article Date: 23 Oct 2007 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


A report released 22nd October identifies signs of maturity in Australian biotechnology along with a continued need for early stage investment support.

The Beyond Discovery 2007 report looks at the research origins and commercial experiences of 68 health biotech companies in Australia.

"While it is still early days for Australian biotechnology, there are promising signs of growth and maturity in the sector," Research Australia CEO Rebecca James said.

The main findings of the survey were:

* 25% of respondents had revenues of between $2 and $10 million;

* 10% of respondents had revenues in excess of $10 million per annum;

* Most biotechs are in the start up phase (32%) with revenues below $2 million;

* Almost half the companies surveyed (49%) derived incomes from selling products or services and one third (34%) from licensing Intellectual property;

* 10% reported they are profitable;

* 41% are currently exporting, and 60% are planning to export in the next 12 months;

* Companies are increasingly contributing to early research -- up from 15% in 2004 to 24% in 2007 -- now similar to that from universities (21%);

* The need for funding remains the most significant hurdle (56%) for advancement;

* A significant increase in access to government funding support, up from 17% in 2004 to 26% in 2007;

* Over half the companies have difficulty in attracting appropriate staff.

The study, launched in Brisbane by Queensland Chief Scientist, Professor Peter Andrews was conducted by Dr Noel Chambers, of Centuris, and guided by a steering committee Chaired by Professor Michael Vitale, Director, Commercialisation, Monash Asia- Pacific Centre for Science and Wealth Creation.

"Research Australia thanks AusBiotech and Medicines Australia for their participation and support for the study, along with GlaxoSmithKline and contributors," Ms James said.

###

About Research Australia

Research Australia is a national alliance of over 190 member and donor organisations with a common mission to make health and medical research a higher national priority. To access the report visit http://www.researchaustralia.org/

Enquiries: Rebecca James, Dr Noel Chambers

Source: Rebecca James
Research Australia

Article adapted by Medical News Today from original press release.
Visit our biology / biochemistry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Rebecca James. "Report On Australian Biotechnology." Medical News Today. MediLexicon, Intl., 23 Oct. 2007. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/86282.php>

APA
Rebecca James. (2007, October 23). "Report On Australian Biotechnology." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/86282.php.

Please note: If no author information is provided, the source is cited instead.


Biology / Biochemistry

Most Popular Articles



Follow Our Biology News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Biology / Biochemistry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »